Immunogenicity of peptides simulating a neutralization epitope of transmissible gastroenteritis virus. 1991

W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
Central Veterinary Institute, Lelystad, The Netherlands.

Previously, an epitope recognized by a set of neutralizing monoclonal antibodies directed against the S protein of transmissible gastroenteritis has been identified. This neutralization epitope can be simulated by a single peptide combining residues 380 to 387 and 1176 to 1184 of the S protein; this combination peptide (SFFSYGEI-QLAKDKVNE) was more antigenic than it single constituents. Here we describe the immunogenicity of this combination peptide, in comparison with monomer and tandem peptides of both constituents, and with a cyclic peptide consisting of residues 373 to 398. All antisera, raised in rabbits, bound to the peptide used as immunogen. Only sera that recognized the residues 380 to 387 bound to whole virus. Three of the four antisera with the highest binding titers to whole virus also had neutralization activity. Analysis of the fine-specificity of the antisera with PEPSCAN peptides indicated that the spectrum of antibodies induced by the 380 to 387 sequence depended on the presentation of this sequence in a peptide to the immune system. The nonbinding and nonneutralizing anti-(380 to 387)-sera appeared to contain a limited spectrum of antipeptide antibodies. Furthermore, the lack of neutralization of the antiserum against the combination peptide could be explained by the immunodominance in rabbits of the 1176 to 1184 sequence over the 380 to 387 sequence. These findings demonstrate a few fundamental problems of simulating discontinuous epitopes by single synthetic peptides.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005760 Transmissible gastroenteritis virus A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old. Gastroenteritis Virus of Swine,Gastroenteritis Virus, Porcine Transmissible,Porcine Transmissible Gastroenteritis Virus,TGE Virus,Transmissible Gastroenteritis Virus, Swine,Swine Gastroenteritis Virus,Swine Gastroenteritis Viruses,TGE Viruses
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
January 1987, Advances in experimental medicine and biology,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
October 1986, Journal of virology,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
April 1976, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
January 1987, Advances in experimental medicine and biology,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
February 1979, The Journal of general virology,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
August 1990, Virology,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
January 1969, National Institute of Animal Health quarterly,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
January 2019, Acta virologica,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
March 1988, American journal of veterinary research,
W P Posthumus, and J A Lenstra, and A P van Nieuwstadt, and W M Schaaper, and B A van der Zeijst, and R H Meloen
November 1992, Journal of virology,
Copied contents to your clipboard!